GLP-1 plays a crucial role in regulating blood sugar levels by stimulating insulin secretion, inhibiting glucagon release, and slowing gastric emptying
Studies show that patients who are obese or overweight using injectable GLP-1 agonist medications for weight loss, combined with diet and exercise, achieve weight loss of approximately 6% of their body weight at 4 months, 9% at 6 months, and 13% at 12 months
Diet, Exercise, and Lifestyle: Optimizing Your GLP-1 Medication Journey Achieving the best weight loss with GLP-1 medication often involves a vital approach that considers various individual factors influencing your unique treatment experience
That is an understandable query, particularly for patients who are anxious about injections or who travel frequently, but it is not the only question clinicians should be asking
Cyclophosphamide induced oxidative stress, lipid per oxidation, apoptosis and histopathological changes in rats: protective role of boron